SCHEMBL6205162

SCHEMBL6205162

CCOc1c(C=O)cccc1N(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
ALDH1A1 P00352 5/20 0.38
GAA P10253 2/20 0.38
HTT P42858 2/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 2/20 0.37
SRC P12931 1/20 0.36
NR3C1 P04150 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
MEN1 O00255 1/20 0.34
THRB P10828 1/20 0.34
BLM P54132 1/20 0.34
KMT2A Q03164 1/20 0.34
ERN1 O75460 2/20 0.34
TLR2 O60603 1/20 0.34
TLR1 Q15399 1/20 0.34
TLR6 Q9Y2C9 1/20 0.34
GSK3A P49840 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6426744 0.83 KDM4E (0.33) ALDH1A1GAASMN1; SMN2NR3C1GSK3A
SCHEMBL16039680 0.81 CCNB2 (0.43) ALDH1A1GAAHTTHPGDSMN1; SMN2
SCHEMBL4595705 0.81 CA1 (0.58) CA1CA2ALDH1A1GAALMNA
SCHEMBL8429714 0.79 ALDH1A1 (0.36) CA1CA2ALDH1A1GAAHTT
SCHEMBL181586 0.77 ALDH1A1 (0.50) CA1CA2ALDH1A1GAAHTT
SCHEMBL27754527 0.77 CA1 (0.44) CA1CA2ALDH1A1GAAHTT
SCHEMBL1253501 0.77 ALDH1A1 (0.50) CA1CA2ALDH1A1GAAHTT
SCHEMBL29922833 0.77 ALDH1A1 (0.50) CA1CA2ALDH1A1GAAHTT
SCHEMBL14292801 0.77 CA1 (0.44) CA1CA2ALDH1A1GAAHTT
SCHEMBL13263976 0.77 TDP1 (0.38) CA1CA2ALDH1A1GAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1551841-A1 PYRAZOLOPYRIMIDINES AS KINASE INHIBITORS SmithKline Beecham Corporation (US) 2005-07-13 EP disclosed
WO-2004009602-A1 PYRAZOLOPYRIMIDINES AS KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2004-01-29 WO disclosed